These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

789 related items for PubMed ID: 25497527

  • 1. Individual-patient visit-by-visit office and ambulatory blood pressure measurements over 24months in patients undergoing renal denervation for hypertension.
    Lambert T, Gammer V, Nahler A, Blessberger H, Kammler J, Grund M, Kerschner K, Buchmayr G, Saleh K, Kypta A, Hönig S, Wichert-Schmitt B, Schwarz S, Sihorsch K, Reiter C, Steinwender C.
    Int J Cardiol; 2015 Feb 15; 181():96-101. PubMed ID: 25497527
    [Abstract] [Full Text] [Related]

  • 2. Influence of pseudo-resistance on the effect of renal denervation on 24-hour ambulatory blood pressure levels.
    Lambert T, Nahler A, Reiter C, Gammer V, Blessberger H, Kammler J, Grund M, Saleh K, Schwarz S, Steinwender C.
    Catheter Cardiovasc Interv; 2015 Sep 15; 86(3):E126-30. PubMed ID: 26033366
    [Abstract] [Full Text] [Related]

  • 3. Ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension.
    Mahfoud F, Ukena C, Schmieder RE, Cremers B, Rump LC, Vonend O, Weil J, Schmidt M, Hoppe UC, Zeller T, Bauer A, Ott C, Blessing E, Sobotka PA, Krum H, Schlaich M, Esler M, Böhm M.
    Circulation; 2013 Jul 09; 128(2):132-40. PubMed ID: 23780578
    [Abstract] [Full Text] [Related]

  • 4. Renal denervation in moderate treatment-resistant hypertension.
    Ott C, Mahfoud F, Schmid A, Ditting T, Sobotka PA, Veelken R, Spies A, Ukena C, Laufs U, Uder M, Böhm M, Schmieder RE.
    J Am Coll Cardiol; 2013 Nov 12; 62(20):1880-6. PubMed ID: 23850901
    [Abstract] [Full Text] [Related]

  • 5. Impact of multi-electrode renal sympathetic denervation on short-term blood pressure variability in patients with drug-resistant hypertension. Insights from the EnligHTN I study.
    Tsioufis C, Papademetriou V, Tsiachris D, Kasiakogias A, Kordalis A, Thomopoulos C, Dimitriadis K, Tousoulis D, Stefanadis C, Parati G, Worthley S.
    Int J Cardiol; 2015 Feb 01; 180():237-42. PubMed ID: 25463375
    [Abstract] [Full Text] [Related]

  • 6. Orthostatic function after renal sympathetic denervation in patients with resistant hypertension.
    Lenski M, Mahfoud F, Razouk A, Ukena C, Lenski D, Barth C, Linz D, Laufs U, Kindermann I, Böhm M.
    Int J Cardiol; 2013 Nov 30; 169(6):418-24. PubMed ID: 24157238
    [Abstract] [Full Text] [Related]

  • 7. Effects of renal denervation on ambulatory blood pressure measurements in patients with resistant arterial hypertension.
    Lambert T, Blessberger H, Gammer V, Nahler A, Grund M, Kerschner K, Buchmayr G, Saleh K, Kammler J, Steinwender C.
    Clin Cardiol; 2014 May 30; 37(5):307-11. PubMed ID: 24700288
    [Abstract] [Full Text] [Related]

  • 8. Effect of catheter-based renal sympathetic denervation on 24-h ambulatory blood pressure in patients with resistant hypertension.
    Völz S, Andersson B, Manhem K, Haraldsson I, Rundqvist B.
    Blood Press; 2014 Aug 30; 23(4):228-32. PubMed ID: 24432803
    [Abstract] [Full Text] [Related]

  • 9. Adjusted drug treatment is superior to renal sympathetic denervation in patients with true treatment-resistant hypertension.
    Fadl Elmula FE, Hoffmann P, Larstorp AC, Fossum E, Brekke M, Kjeldsen SE, Gjønnæss E, Hjørnholm U, Kjaer VN, Rostrup M, Os I, Stenehjem A, Høieggen A.
    Hypertension; 2014 May 30; 63(5):991-9. PubMed ID: 24591332
    [Abstract] [Full Text] [Related]

  • 10. The randomised Oslo study of renal denervation vs. Antihypertensive drug adjustments: efficacy and safety through 7 years of follow-up.
    Bergland OU, Søraas CL, Larstorp ACK, Halvorsen LV, Hjørnholm U, Hoffman P, Høieggen A, Fadl Elmula FEM.
    Blood Press; 2021 Feb 30; 30(1):41-50. PubMed ID: 33030064
    [Abstract] [Full Text] [Related]

  • 11. Effects of catheter-based renal denervation on cardiac sympathetic activity and innervation in patients with resistant hypertension.
    Donazzan L, Mahfoud F, Ewen S, Ukena C, Cremers B, Kirsch CM, Hellwig D, Eweiwi T, Ezziddin S, Esler M, Böhm M.
    Clin Res Cardiol; 2016 Apr 30; 105(4):364-71. PubMed ID: 26493305
    [Abstract] [Full Text] [Related]

  • 12. Impact of local vascular lesions assessed with optical coherence tomography and ablation points on blood pressure reduction after renal denervation.
    Ghadri JR, Gaehwiler R, Jaguszewski M, Sudano I, Osipova J, Schoenenberger-Berzins R, Erne P, Lüscher TF, Templin C.
    Swiss Med Wkly; 2015 Apr 30; 145():w14102. PubMed ID: 25658048
    [Abstract] [Full Text] [Related]

  • 13. Sustained sympathetic and blood pressure reduction 1 year after renal denervation in patients with resistant hypertension.
    Hering D, Marusic P, Walton AS, Lambert EA, Krum H, Narkiewicz K, Lambert GW, Esler MD, Schlaich MP.
    Hypertension; 2014 Jul 30; 64(1):118-24. PubMed ID: 24732891
    [Abstract] [Full Text] [Related]

  • 14. Catheter-based renal denervation for resistant hypertension: Twenty-four month results of the EnligHTN I first-in-human study using a multi-electrode ablation system.
    Tsioufis CP, Papademetriou V, Dimitriadis KS, Kasiakogias A, Tsiachris D, Worthley MI, Sinhal AR, Chew DP, Meredith IT, Malaiapan Y, Thomopoulos C, Kallikazaros I, Tousoulis D, Worthley SG.
    Int J Cardiol; 2015 Dec 15; 201():345-50. PubMed ID: 26301677
    [Abstract] [Full Text] [Related]

  • 15. Renal denervation in treatment-resistant essential hypertension. A randomized, SHAM-controlled, double-blinded 24-h blood pressure-based trial.
    Mathiassen ON, Vase H, Bech JN, Christensen KL, Buus NH, Schroeder AP, Lederballe O, Rickers H, Kampmann U, Poulsen PL, Hansen KW, Btker HE, Peters CD, Engholm M, Bertelsen JB, Lassen JF, Langfeldt S, Andersen G, Pedersen EB, Kaltoft A.
    J Hypertens; 2016 Aug 15; 34(8):1639-47. PubMed ID: 27228432
    [Abstract] [Full Text] [Related]

  • 16. Vascular and renal hemodynamic changes after renal denervation.
    Ott C, Janka R, Schmid A, Titze S, Ditting T, Sobotka PA, Veelken R, Uder M, Schmieder RE.
    Clin J Am Soc Nephrol; 2013 Jul 15; 8(7):1195-201. PubMed ID: 23559677
    [Abstract] [Full Text] [Related]

  • 17. Meta-analysis of randomized controlled trials of renal denervation in treatment-resistant hypertension.
    Fadl Elmula FE, Jin Y, Yang WY, Thijs L, Lu YC, Larstorp AC, Persu A, Sapoval M, Rosa J, Widimský P, Jacobs L, Renkin J, Petrák O, Chatellier G, Shimada K, Widimský J, Kario K, Azizi M, Kjeldsen SE, Staessen JA, European Network Coordinating Research On Renal Denervation (ENCOReD) Consortium.
    Blood Press; 2015 Jul 15; 24(5):263-74. PubMed ID: 26194721
    [Abstract] [Full Text] [Related]

  • 18. Renal denervation with cryoenergy as second-line option is effective in the treatment of resistant hypertension in non-responders to radiofrequency ablation.
    Prochnau D, Heymel S, Otto S, Figulla HR, Surber R.
    EuroIntervention; 2014 Sep 15; 10(5):640-5. PubMed ID: 25256203
    [Abstract] [Full Text] [Related]

  • 19. Renal sympathetic denervation as second-line therapy in mild resistant hypertension: a pilot study.
    Kaltenbach B, Franke J, Bertog SC, Steinberg DH, Hofmann I, Sievert H.
    Catheter Cardiovasc Interv; 2013 Feb 15; 81(2):335-9. PubMed ID: 22807098
    [Abstract] [Full Text] [Related]

  • 20. Intraprocedural reduction of the veno-arterial norepinephrine gradient correlates with blood pressure response after renal denervation.
    Tiroch K, Sause A, Szymanski J, Nover I, Leischik R, Mann JF, Vorpahl M, Seyfarth M.
    EuroIntervention; 2015 Nov 15; 11(7):824-34. PubMed ID: 26603990
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.